短链脂肪酸在2型糖尿病中的作用研究进展  

Advances in the Role of Short-chain Fatty Acids in Type 2 Diabetes

作　　者：姜荣生 张龙 管其凡 张静 吴元丰 刘明军[1] JIANG Rongsheng;ZHANG Long;GUAN Qifan;ZHANG Jing;WU Yuanfeng;LIU Mingjun(School of Acupuncture and Tuina,Changchun University of Chinese Medicine,Changchun 130117,China)

机构地区：[1]长春中医药大学针灸推拿学院,吉林省长春市130117

出　　处：《中国全科医学》2024年第24期3031-3037,共7页Chinese General Practice

基　　金：国家自然科学基金资助项目(82174525);吉林省科技发展计划项目(YDZJ202201ZYTS195)。

摘　　要：短链脂肪酸(SCFAs)在肠道微生物群调控宿主代谢中起到了主要介导作用,且与2型糖尿病(T2DM)密切相关,可改善T2DM患者的血糖、体质量和血脂指标。尽管有学者认为SCFAs有望成为T2DM的新型治疗靶点,但目前尚未有相关综述。本文总结了短链脂肪酸的生物学特性,讨论了SCFAs调节食欲、炎症、胰岛β细胞、脂质代谢与肝脏糖原代谢的证据,进一步明确调控SCFAs在T2DM中的作用及其研究进展,探讨了调控SCFAs治疗T2DM的潜力。Short-chain fatty acids(SCFAs)play a major mediating role in gut microbiota regulation of host metabolism and are strongly associated with type 2 diabetes mellitus(T2DM),which improves glycemic,body weight,and lipid indices in T2DM patients.Although it has been suggested that SCFAs are expected to be novel therapeutic targets for T2DM,no review has been conducted.Therefore,this paper summarizes the biological properties of SCFAs,discusses the evidence that SCFAs regulate appetite,inflammation,pancreaticβ-cells,lipid metabolism and hepatic glycogen metabolism,further clarifies the progress of research on regulating the role of SCFAs in T2DM and their mechanisms,and explores the potential of regulating SCFAs for the treatment of T2DM.

关 键 词：糖尿病 2型 短链脂肪酸 胃肠道微生物组 代谢 研究进展 

分 类 号：R587.1[医药卫生—内分泌]